{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:37:32Z","timestamp":1772343452006,"version":"3.50.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,4,29]],"date-time":"2003-04-29T00:00:00Z","timestamp":1051574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s00467-003-1146-9","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:23:04Z","timestamp":1576120984000},"page":"623-635","source":"Crossref","is-referenced-by-count":49,"title":["Renal function following hematological stem cell transplantation in childhood"],"prefix":"10.1007","volume":"18","author":[{"given":"Ludwig","family":"Patzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Kentouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Ringelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Misselwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,29]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s004670050585","volume":"13","author":"Rossi","year":"1999","unstructured":"Rossi R, Kleta R, Ehrich JH (1999) Renal involvement in children with malignancies. Pediatr Nephrol 13:153\u2013162","journal-title":"Pediatr Nephrol"},{"key":"1146_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/12.6.1091","volume":"12","author":"Rossi","year":"1997","unstructured":"Rossi R (1997) Nephrotoxicity of ifosfamide\u2014moving towards understanding the molecular mechanisms. Nephrol Dial Transplant 12:1091\u20131092","journal-title":"Nephrol Dial Transplant"},{"key":"1146_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.3.CO;2-8","volume":"32","author":"Rossi","year":"1999","unstructured":"Rossi R, Pleyer J, Schafers P, Kuhn N, Kleta R, Deufel T, Jurgens H (1999) Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 32:177\u2013182","journal-title":"Med Pediatr Oncol"},{"key":"1146_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MCG (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer 82:1636\u20131645","journal-title":"Br J Cancer"},{"key":"1146_CR5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/009127009903900504","volume":"39","author":"Loebstein","year":"1999","unstructured":"Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454\u2013461","journal-title":"J Clin Pharmacol"},{"key":"1146_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00860751","volume":"9","author":"Jones","year":"1995","unstructured":"Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9:206\u2013212","journal-title":"Pediatr Nephrol"},{"key":"1146_CR7","doi-asserted-by":"crossref","unstructured":"Dieperink H, Perico N, Nielsen FT, Remuzzi G (1998) Cyclosporine\/tacrolimus (FK-506). In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins. Kluwer, Dordrecht, pp 275\u2013300","DOI":"10.1007\/978-94-015-9088-4_21"},{"key":"1146_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00002018-199921060-00004","volume":"21","author":"Olyaei","year":"1999","unstructured":"Olyaei AJ, Mattos AM de, Bennett WM (1999) Immunosuppressant-induced nephropathy\u2014pathophysiology, incidence and management. Drug Saf 21:471\u2013488","journal-title":"Drug Saf"},{"key":"1146_CR9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ki.1986.280","volume":"30","author":"Myers","year":"1986","unstructured":"Myers BD (1986) Cyclosporine nephrotoxicity. Kidney Int 30:964\u2013974","journal-title":"Kidney Int"},{"key":"1146_CR10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","volume":"46","author":"Zager","year":"1994","unstructured":"Zager RA (1994) Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443\u20131458","journal-title":"Kidney Int"},{"key":"1146_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000168889","volume":"15","author":"Gruss","year":"1995","unstructured":"Gruss E, Bernis C, Tomas JF, Garciacanton C, Figuera A, Motellon JL, Paraiso V, Traver JA, Fernandezranada JM (1995) Acute renal failure in patients following bone marrow transplantation\u2014prevalence, risk factors and outcome. Am J Nephrol 15:473\u2013479","journal-title":"Am J Nephrol"},{"key":"1146_CR12","first-page":"761","volume":"18","author":"Gruss","year":"1996","unstructured":"Gruss E, Tomas JF, Bernis C, Rodriguez F, Traver JA, Fernandez RJ (1996) Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis. Bone Marrow Transplant 18:761\u2013765","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR13","first-page":"1477","volume":"44","author":"Gruss","year":"1993","unstructured":"Gruss E, Garciacanton C, Tomas JF, Bernis C, Figuera A, Berberana M, Paraiso V, Hernnandezjaraz J, Fdzranada JM, Traver JA (1993) Risk factors for the development of acute renal failure during bone marrow transplantation. Kidney Int 44:1477\u20131492","journal-title":"Kidney Int"},{"key":"1146_CR14","first-page":"985","volume":"69","author":"Kone","year":"1988","unstructured":"Kone BC, Whelton A, Santos G, Saral R, Watson AJ (1988) Hypertension and renal dysfunction in bone marrow transplant recipients. QJM 69:985\u2013995","journal-title":"QJM"},{"key":"1146_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","volume":"62","author":"Parikh","year":"2002","unstructured":"Parikh CR, McSweene, PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones, RB, Bearman SI, Schrier RW (2002) Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62:566\u2013573","journal-title":"Kidney Int"},{"key":"1146_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000045561","volume":"84","author":"Herget-Rosenthal","year":"2000","unstructured":"Herget-Rosenthal S, Uppenkamp M, Beelen D, Kohl D, Kribben A (2000) Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation. Nephron 84:136\u2013141","journal-title":"Nephron"},{"key":"1146_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0272-6386(89)80054-X","volume":"13","author":"Zager","year":"1989","unstructured":"Zager RA, OQuigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED (1989) Acute renal failure following bone marrow transplantation. A retrospective study of 272 patients. Am J Kidney Dis 13:210\u2013216","journal-title":"Am J Kidney Dis"},{"key":"1146_CR18","first-page":"383","volume":"7","author":"VanWhy","year":"1991","unstructured":"VanWhy SK, Friedman AL, Wei LJ, Hong R (1991) Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7:383\u2013388","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bmt.1701388","volume":"22","author":"Kist-van","year":"1998","unstructured":"Kist-van Holthe JE, Zwet JM van, Brand R, Weel MH van, Vossen JM, Heijden AJ van der (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22:559\u2013564","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","volume":"7","author":"Bearman","year":"1989","unstructured":"Bearman SI, Appelbaum FR, Back A, Petersen FB, Buckner CD, Sullivan KM, Schoch HG, Fisher LD, Thomas ED (1989) Regimen related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 7:1288\u20131294","journal-title":"J Clin Oncol"},{"key":"1146_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/sj.bmt.1703337","volume":"29","author":"Balduzzi","year":"2002","unstructured":"Balduzzi A, Valsecchi MG, Silvestri D, Locatelli F, Manfredini L, Busca A, Iori AP, Messina C, Prete A, Andolina M, Porta F, Favre C, Ceppi S, Giorgiani G, Lanino E, Rovelli A, Fagioli F, De Fusco C, Rondelli R, Uderzo C (2002) Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia. Bone Marrow Transplant 29:93\u2013100","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR22","unstructured":"Kentouche K (1999) Akute Niereninsuffizienz innerhalb der ersten 30\u00a0Tage nach Knochenmarktransplantation bei Kindern. Doctoral Thesis. Friedrich Schiller University, Jena"},{"key":"1146_CR23","first-page":"613","volume":"13","author":"Lane","year":"1994","unstructured":"Lane PH, Mauer SM, Blazar BR, RamsaY, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13:613\u2013617","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR24","first-page":"3092","volume":"21","author":"Berg","year":"1989","unstructured":"Berg U, Bolme P (1989) Renal function in children following bone marrow transplantation. Transplant Proc 21:3092\u20133094","journal-title":"Transplant Proc"},{"key":"1146_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<274::AID-MPO6>3.0.CO;2-F","volume":"28","author":"Patzer","year":"1997","unstructured":"Patzer L, Hempel L, Ringelmann F, Misselwitz J, Fuchs D, Zintl F, Brandis M, DeBroe ME, Zimmerhackl LB (1997) Renal function after conditioning therapy for bone marrow transplantation in childhood. Med Pediatr Oncol 28:274\u2013283","journal-title":"Med Pediatr Oncol"},{"key":"1146_CR26","first-page":"173","volume":"38","author":"L Patzer","year":"1999","unstructured":"Patzer L, Ringelmann F, Kentouche K, Zintl F, Misselwitz J (1999) Ungew\u00f6hnlicher Verlauf eines deToni-Debr\u00e9-Fanconi Syndroms nach Ifosfamidtherapie. P\u00e4diatr Grenzgeb 38:173\u2013183","journal-title":"P\u00e4diatr Grenzgeb"},{"key":"1146_CR27","first-page":"C40","volume":"13","author":"Kapinga","year":"2000","unstructured":"Kapinga E, Kardos G, Deure J van der, Wijk JAE van (2000) Impaired renal function in children with renal tumors treated with nephrectomy, high dose chemotherapy and abdominal radiotherapy. Pediatr Nephrol 13:C40","journal-title":"Pediatr Nephrol"},{"key":"1146_CR28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-2008-1046471","volume":"208","author":"Hempel","year":"1996","unstructured":"Hempel L, Kremens B, Weirich A, Graf N, Zintl F, Ludwig R (1996) High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP9\/GPOH trial and study. Klin Padiatr 208:186\u2013189","journal-title":"Klin Padiatr"},{"key":"1146_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mpo.2950220103","volume":"22","author":"Garaventa","year":"1994","unstructured":"Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Castel V, Dallorso S, Adelbost Z, Ladenstein R, Chauvin F, Phillip T (1994) Autologous bone marrow transplantation for pediatric Wilms tumor. The experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 22:11\u201314","journal-title":"Med Pediatr Oncol"},{"key":"1146_CR30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1702763","volume":"27","author":"Patzer","year":"2001","unstructured":"Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J (2001) Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27:319\u2013327","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08880019809028793","volume":"15","author":"Hempel","year":"1998","unstructured":"Hempel L, Patzer L, Misselwitz J, Fuchs D, Zintl F (1998) Complete recovery of renal function in a Wilms' tumor patient after acute renal failure caused by autologous bone marrow transplantation (ABMT). Pediatr Hematol Oncol 15:255\u2013260","journal-title":"Pediatr Hematol Oncol"},{"key":"1146_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders\u2014incidence, prevention and management. Drug Saf 24:19\u201338","journal-title":"Drug Saf"},{"key":"1146_CR33","doi-asserted-by":"crossref","unstructured":"SandersJE (1999) Stem-cell transplant preparative regimens. Pediatr Transplant 3 [Suppl 1]:23\u201334","DOI":"10.1034\/j.1399-3046.1999.00073.x"},{"key":"1146_CR34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0959-8049(92)90508-Y","volume":"28A","author":"Gordon","year":"1992","unstructured":"Gordon SJ, Pearson ADJ, Reid MM, Craft AW (1992) Toxicity of single day high dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A:1319\u20131323","journal-title":"Eur J Cancer"},{"key":"1146_CR35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/0959-8049(92)90509-Z","volume":"28A","author":"Corbett","year":"1992","unstructured":"Corbett R, Pinkerton R, Pritchard J, Meller S, Lewis I, Kingston J, Mcelwain T (1992) Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer 28A:1324\u20131328","journal-title":"Eur J Cancer"},{"key":"1146_CR36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mpo.2950230603","volume":"23","author":"Cole","year":"1994","unstructured":"Cole CH, Pritchard S, Rogers PCJ, Davis JE, Phillips G, Chan KW (1994) Intensive conditioning regimen for bone marrow transplantation in children with high risk hematological malignancies. Med Pediatr Oncol 23:464\u2013469","journal-title":"Med Pediatr Oncol"},{"key":"1146_CR37","first-page":"449","volume":"14","author":"Przepiorka","year":"1994","unstructured":"Przepiorka D, Ippoliti C, Giralt S, VanBeisen K, Mehra R, Deisseroth AB, Andersson B, Luna M, Cork A, Lee M, Estey E, Andreeff M, Champlin R (1994) A phase I-II study of high dose thiothepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. Bone Marrow Transplant 14:449\u2013453","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10428199409049679","volume":"14","author":"Rosenthal","year":"1994","unstructured":"Rosenthal MA, Grigg AP, Sheridan WP (1994) High dose busulfan\/cyclophosphamide for autologous bone marrow transplantation is associated with minimal nonhematopoietic toxicity. Leuk Lymphoma 14:279\u2013283","journal-title":"Leuk Lymphoma"},{"key":"1146_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01834364","volume":"68","author":"Przepiorka","year":"1994","unstructured":"Przepiorka D, Dimopoulos M, Smith T, Ippoliti C, Diener K, Luna M, Champlin RE (1994) Thiotepa, busulfan and cyclophosphamide as a preparative regimen for marrow transplantation. Risk factors for early regimen related toxicity. Ann Hematol 68:183\u2013188","journal-title":"Ann Hematol"},{"key":"1146_CR40","first-page":"515","volume":"10","author":"Cowen","year":"1992","unstructured":"Cowen D, Richaud P, Marit G, Conymakhoul P, Trouette R, Faberes C, Reiffers J (1992) Regimen related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique. Bone Marrow Transplant 10:515\u2013519","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR41","first-page":"25","volume":"5","author":"Kessinger","year":"1990","unstructured":"Kessinger A, SchmitpokornyK, Smith D, Armitage J (1990) Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 5:25\u201327","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(80)92158-3","volume":"II","author":"Yellowlees","year":"1980","unstructured":"Yellowlees P, Greenfield C, McIntyre N (1980) Dimethylsulfoxyde-induced toxicity. Lancet II:1004\u20131006","journal-title":"Lancet"},{"key":"1146_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08860229209106640","volume":"14","author":"Zager","year":"1992","unstructured":"Zager RA (1992) Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels. Implications for therapy of myoglobin induced renal injury. Ren Fail 14:341\u2013344","journal-title":"Ren Fail"},{"key":"1146_CR44","unstructured":"Zager RA (1998) Isolated proximal tubular segment experiments in the study of nephrotoxic acute renal failure. In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) Clinical nephrotoxins. Kluwer, Dordrecht, pp 61\u201399"},{"key":"1146_CR45","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0002-9440(10)65024-9","volume":"156","author":"Nath","year":"2000","unstructured":"Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J (2000) The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156:1527\u20131535","journal-title":"Am J Pathol"},{"key":"1146_CR46","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1073\/pnas.92.15.6798","volume":"92","author":"Abraham","year":"1995","unstructured":"Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, Kappas A (1995) Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial-cells. Protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci U S A 92:6798\u20136802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1146_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1172\/JCI115847","volume":"90","author":"Nath","year":"1992","unstructured":"Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME (1992) Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90:267\u2013270","journal-title":"J Clin Invest"},{"key":"1146_CR48","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1172\/JCI6163","volume":"103","author":"Yet","year":"1999","unstructured":"Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103:R23\u2013R29","journal-title":"J Clin Invest"},{"key":"1146_CR49","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1073\/pnas.94.20.10925","volume":"94","author":"Poss","year":"1997","unstructured":"Poss KD, Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 94:10925\u201310930","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1146_CR50","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.2000.278.5.F726","volume":"278","author":"Shiraishi","year":"2000","unstructured":"Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A (2000) Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278:F726\u2013F736","journal-title":"Am J Physiol Renal Physiol"},{"key":"1146_CR51","first-page":"A2836","volume":"8","author":"Shiraishi","year":"1997","unstructured":"Shiraishi F, Nick HS, Tisher CC, Agarwal A (1997) Prior induction of heme oxygenase-1 attenuates cisplatin-mediated toxicity in human proximal tubule cells (HPTC). J Am Soc Nephrol 8:A2836","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1006889427520","volume":"178","author":"Husain","year":"1998","unstructured":"Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM (1998) Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 178:127\u2013133","journal-title":"Mol Cell Biochem"},{"key":"1146_CR53","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ki.1995.414","volume":"48","author":"Agarwal","year":"1995","unstructured":"Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA (1995) Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298\u20131307","journal-title":"Kidney Int"},{"key":"1146_CR54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1081\/DMR-100101947","volume":"31","author":"Baliga","year":"1999","unstructured":"Baliga R, Ueda N, Walker PD, Shah SV (1999) Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31:971\u2013997","journal-title":"Drug Metab Rev"},{"key":"1146_CR55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/08860229909085109","volume":"21","author":"Walker","year":"1999","unstructured":"Walker PD, Barri Y, Shah SV (1999) Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 21:433\u2013442","journal-title":"Ren Fail"},{"key":"1146_CR56","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1046\/j.1523-1755.1998.00161.x","volume":"54","author":"Baliga","year":"1998","unstructured":"Baliga R, Zhang ZW, Baliga M, Ueda N, Shah SV (1998) Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 54:1562\u20131569","journal-title":"Kidney Int"},{"key":"1146_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1523-1755.1998.00767.x","volume":"53","author":"Baliga","year":"1998","unstructured":"Baliga R, Zhang ZW, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394\u2013401","journal-title":"Kidney Int"},{"key":"1146_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1523-1755.1998.00731.x","volume":"53","author":"Nath","year":"1998","unstructured":"Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H (1998) Intracellular targets in heme protein-induced renal injury. Kidney Int 53:100\u2013111","journal-title":"Kidney Int"},{"key":"1146_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s004670050077","volume":"10","author":"VanRoey","year":"1996","unstructured":"VanRoey G, Moore K (1996) The hepatorenal syndrome. Pediatr Nephrol 10:100\u2013107","journal-title":"Pediatr Nephrol"},{"key":"1146_CR60","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1182\/blood.V90.9.3799","volume":"90","author":"Locasciulli","year":"1997","unstructured":"Locasciulli A, Testa M, Valsecchi MG, Vecchi L, Longoni D, Sparano P, Rovelli A, Uderzo C, Masera G, Alberti A (1997) Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood 90:3799\u20133805","journal-title":"Blood"},{"key":"1146_CR61","doi-asserted-by":"crossref","unstructured":"Ribaud P, Gluckman E (1999) Hepatic veno-occlusive disease. Pediatr Transplant 3 [Suppl 1]:41\u201344","DOI":"10.1034\/j.1399-3046.1999.00077.x"},{"key":"1146_CR62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.bmt.1702453","volume":"26","author":"Kim","year":"2000","unstructured":"Kim BK, Chung KW, Sun HS, Suh JG, Min WS, Kang CS, Sim SI, Shin WS, Kim CC (2000) Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 26:193\u2013197","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR63","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"Bearman","year":"1995","unstructured":"Bearman SI (1995) The syndrome of hepatic venoocclusive disease after marrow transplantation. Blood 85:3005\u20133020","journal-title":"Blood"},{"key":"1146_CR64","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1182\/blood.V98.12.3234","volume":"98","author":"Bach","year":"2001","unstructured":"Bach PB, Schrag D, Nierman DM, Horak D, White P, Young JW, Groeger JS (2001) Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 98:3234\u20133240","journal-title":"Blood"},{"key":"1146_CR65","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1681\/ASN.V661655","volume":"6","author":"Fink","year":"1995","unstructured":"Fink JC, Cooper MA, Burkhart KM, McDonald GB, Zager RA (1995) Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced \"hepatorenal syndrome\". J Am Soc Nephrol 6:1655\u20131660","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR66","first-page":"495","volume":"14","author":"Pettitt","year":"1994","unstructured":"Pettitt AR, Clark RE (1994) Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14:495\u2013504","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR67","first-page":"126","volume":"34","author":"Schriber","year":"1997","unstructured":"Schriber JR, Herzig GP (1997) Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 34:126\u2013133","journal-title":"Semin Hematol"},{"key":"1146_CR68","doi-asserted-by":"crossref","unstructured":"DeBroe ME, Porter GA, Bennett WM, Verpooten GA (eds) (1998) Clinical nephrotoxins, 1st edn. Kluwer, Dordrecht","DOI":"10.1007\/978-94-015-9088-4"},{"key":"1146_CR69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1179\/joc.2001.13.5.461","volume":"13","author":"Fanos","year":"2001","unstructured":"Fanos V, Cataldi L (2001) Renal transport of antibiotics and nephrotoxicity: a review. J Chemother 13:461\u2013472","journal-title":"J Chemother"},{"key":"1146_CR70","first-page":"24","volume":"12","author":"Boubenider","year":"1999","unstructured":"Boubenider S, Hiesse C, Marchand S, Hafi A, Kriaa F, Charpentier B (1999) Post-transplantation polyomavirus infections. J Nephrol 12:24\u201329","journal-title":"J Nephrol"},{"key":"1146_CR71","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1086\/321813","volume":"33","author":"Reploeg","year":"2001","unstructured":"Reploeg MD, Storch GA, Clifford DB (2001) BK virus: a clinical review. Clin Infect Dis 33:191\u2013202","journal-title":"Clin Infect Dis"},{"key":"1146_CR72","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bmt.1703187","volume":"28","author":"Bielorai","year":"2001","unstructured":"Bielorai B, Shulman LM, Rechavi G, Toren A (2001) CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantation. Bone Marrow Transplant 28:613\u2013614","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR73","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s004310050047","volume":"159","author":"Peinemann","year":"2000","unstructured":"Peinemann F, Villiers EM de, Doorries K, Adams O, Vogeli TA, Burdach S (2000) Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr 159:182\u2013188","journal-title":"Eur J Pediatr"},{"key":"1146_CR74","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1995.13.5.1103","volume":"13","author":"Bedi","year":"1995","unstructured":"Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P, Arthur RR, Jones RJ (1995) Association of BK-virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 13:1103\u20131109","journal-title":"J Clin Oncol"},{"key":"1146_CR75","first-page":"1650","volume":"98","author":"Leung","year":"2001","unstructured":"Leung AYH, Chow HCH, Liang R, Lie AKW, Kwong YL (2001) Quantitative and genotypic analysis of polyoma BK viruria during hemorrhagic cystitis complicating bone marrow transplantation. Blood 98:1650","journal-title":"Blood"},{"key":"1146_CR76","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/bbmt.2001.v7.pm11529489","volume":"7","author":"Hoffman","year":"2001","unstructured":"Hoffman JA, Shah AJ, Ross LA, Kapoor N (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. BiolBlood Marrow Transplant 7:388\u2013394","journal-title":"BiolBlood Marrow Transplant"},{"key":"1146_CR77","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/archinte.1986.00360190186026","volume":"146","author":"Ambinder","year":"1986","unstructured":"Ambinder RF, Burns W, Forman M, Charache P, Arthur R, Beschorner W, Santos G, Saral R (1986) Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 146:1400\u20131401","journal-title":"Arch Intern Med"},{"key":"1146_CR78","first-page":"109","volume":"2","author":"Miyamura","year":"1987","unstructured":"Miyamura K, Minami S, Matsuyama T, Kodera Y, Yamauchi T, Tahara T, Sao H, Morishima Y, Yokomaku S (1987) Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation. Bone Marrow Transplant 2:109\u2013110","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR79","first-page":"533","volume":"4","author":"Miyamura","year":"1989","unstructured":"Miyamura K, Takeyama K, Kojima S, Minami S, Matsuyama K, Morishima Y, Kodera Y (1989) Hemorrhagic cystitis associated with urinary excretion of adenovirus type-11 following bone marrow transplantation. Bone Marrow Transplant 4:533\u2013535","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR80","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199310000-00020","volume":"56","author":"Sencer","year":"1993","unstructured":"Sencer SF, Haake RJ, Weisdorf DJ (1993) Hemorrhagic cystitis after bone marrow transplantation\u2014risk factors and complications. Transplantation 56:875\u2013879","journal-title":"Transplantation"},{"key":"1146_CR81","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.bmt.1701482","volume":"22","author":"Kondo","year":"1998","unstructured":"Kondo M, Kojima S, Kato K, Matsuyama T (1998) Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 22:995\u2013998","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR82","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/rmv.299","volume":"11","author":"Dockrell","year":"2001","unstructured":"Dockrell DH, Paya CV (2001) Human herpesvirus-6 and-7 in transplantation. Rev Med Virol 11:23\u201336","journal-title":"Rev Med Virol"},{"key":"1146_CR83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00007890-199301000-00013","volume":"55","author":"Yuzawa","year":"1993","unstructured":"Yuzawa Y, Aoi N, Fukatsu A, IchidA S, Yoshida F, Akatsuka Y, Minami S, Kodera Y, Matsuo S (1993) Acute renal failure and degenerative tubular lesions associated with in situ formation of adenovirus immune-complexes in a patient with allogeneic bone marrow transplantation. Transplantation 55:67\u201372","journal-title":"Transplantation"},{"key":"1146_CR84","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1034\/j.1399-3046.2001.00037.x","volume":"5","author":"Lin","year":"2001","unstructured":"Lin PL, Vats AN, Green M (2001) BK virus infection in renal transplant recipients. Pediatr Transplant 5:398\u2013405","journal-title":"Pediatr Transplant"},{"key":"1146_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002800050185","volume":"35","author":"Pinzani","year":"1994","unstructured":"Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P (1994) Cisplatin induced renal toxicity and toxicity-modulating strategies\u2014a review. Cancer Chemother Pharmacol 35:1\u20139","journal-title":"Cancer Chemother Pharmacol"},{"key":"1146_CR86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s002800050661","volume":"40","author":"Stewart","year":"1997","unstructured":"Stewart DJ, Dulberg CS, Mikhael NZ, Redmond MD, Montpetit VA, Goel R (1997) Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods. Cancer Chemother Pharmacol 40:293\u2013308","journal-title":"Cancer Chemother Pharmacol"},{"key":"1146_CR87","first-page":"2279","volume":"14","author":"Bin","year":"1994","unstructured":"Bin P, Boddy AV, English MW, Pearson ADJ, Price L, Tilby MJ, Newell DR (1994) The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in pediatric patients\u2014a review. Anticancer Res 14:2279\u20132283","journal-title":"Anticancer Res"},{"key":"1146_CR88","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.1999.17.10.3333","volume":"17","author":"Hensley","year":"1999","unstructured":"Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ, Mitchell B, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH, Winer EP, Pfister DG (1999) American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 17:3333\u20133355","journal-title":"J Clin Oncol"},{"key":"1146_CR89","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/00000421-200008000-00019","volume":"23","author":"Chauncey","year":"2000","unstructured":"Chauncey TR, Gooley TA, Lloid ME, Schubert MM, Lilleby K, Holmberg L, Bensinger WI (2000) Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Am J Clin Oncol 23:406\u2013411","journal-title":"Am J Clin Oncol"},{"key":"1146_CR90","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bmt.1702694","volume":"26","author":"Cronin","year":"2000","unstructured":"Cronin S, Uberti JP, Ayash LJ, Raith C, Ratanatharathorn V (2000) Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1247\u20131249","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1345\/aph.10041","volume":"35","author":"Quilitz","year":"2001","unstructured":"Quilitz RE, Arnold AD, Briones GR, Dix SP, Ippoliti C, Kennedy LD, Lucich JL, Mehta J, Peters BG, Tice DS (2001) Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients. Ann Pharmacother 35:206\u2013216","journal-title":"Ann Pharmacother"},{"key":"1146_CR92","first-page":"105","volume":"10","author":"Gandemer","year":"2000","unstructured":"Gandemer V, Taque S, Guiguen C, Rambeau M, Sayagh M, Le Gall E (2000) Safety and tolerance of liposomal amphotericin B in the treatment of invasive aspergillosis in a neutropenic adolescent. J Mycol Med 10:105\u2013107","journal-title":"J Mycol Med"},{"key":"1146_CR93","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","volume":"30","author":"Stevens","year":"2000","unstructured":"Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA (2000) Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 30:696\u2013709","journal-title":"Clin Infect Dis"},{"key":"1146_CR94","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1702487","volume":"26","author":"Held","year":"2000","unstructured":"Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR, Siegert W (2000) Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 26:347\u2013350","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR95","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2141.1999.01680.x","volume":"107","author":"Richardson","year":"1999","unstructured":"Richardson P, Guinan E (1999) The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches. Br J Haematol 107:485\u2013493","journal-title":"Br J Haematol"},{"key":"1146_CR96","first-page":"185","volume":"18","author":"Rosenthal","year":"1996","unstructured":"Rosenthal J, Sender L, Secola R, Killen R, Millerick M, Murphy L, Cairo MS (1996) Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Bone Marrow Transplant 18:185\u2013191","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR97","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","volume":"61","author":"Or","year":"1996","unstructured":"Or R, Nagler A, Shpilberg O, Elad S, Naparstek E, Kapelushnik J, Cass Y, Gillis S, Chetrit A, Slavin S, Eldor A (1996) Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation 61:1067\u20131071","journal-title":"Transplantation"},{"key":"1146_CR98","first-page":"439","volume":"5","author":"Baglin","year":"1990","unstructured":"Baglin TP, Harper P, Marcus RE (1990) Venoocclusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen-activator (rt-PA). Bone Marrow Transplant 5:439\u2013441","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR99","first-page":"1107","volume":"90","author":"Richardson","year":"1997","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Waller EK, Antin JH, Soiffer RJ, Vredenburgh J, BEARMAN SI, Iacobelli M, Fareed J, Guinan EC (1997) Treatment of severe veno-occlusive disease (VOD) with defibrotide (DF): compassionate use results in efficacy without significant toxicity in a high risk population. Blood 90:1107","journal-title":"Blood"},{"key":"1146_CR100","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","volume":"89","author":"Bearman","year":"1997","unstructured":"Bearman SI, Lee JL, Baron AE, McDonald GB (1997) Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 89:1501\u20131506","journal-title":"Blood"},{"key":"1146_CR101","unstructured":"Frishberg Y, Kaplan BS (1992) Bone marrow transplantation-associated thrombotic microangiopathy. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Dekker, New York, pp 187\u2013198"},{"key":"1146_CR102","first-page":"271","volume":"16","author":"Sarode","year":"1995","unstructured":"Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C, Garbrecht F, Gottschall JL (1995) Therapeutic plasma-exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura hemolytic-uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 16:271\u2013275","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jca.2920060104","volume":"6","author":"Silva","year":"1991","unstructured":"Silva VA, Frei-Lahr D, Brown RA (1991) Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 6:16\u201320","journal-title":"J Clin Apheresis"},{"key":"1146_CR104","first-page":"898","volume":"17","author":"Chown","year":"1996","unstructured":"Chown SR, Goulden N, Cornish JM, Oakhill A, Pamphilon D, Potter MN (1996) The role of plasma exchange for TTP\/HUS post-bone marrow transplant. Bone Marrow Transplant 17:898\u2013899","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR105","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1526-0968.1999.00168.x","volume":"3","author":"Bosch","year":"1999","unstructured":"Bosch T, Buhmann R, Lennertz A, Samtleben W, Kolb HJ (1999) Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation. Ther Apher 3:252\u2013256","journal-title":"Ther Apher"},{"key":"1146_CR106","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.bmt.1702208","volume":"25","author":"Plews","year":"2000","unstructured":"Plews DE, Turner ML, Wallace WHB (2000) Plasma exchange as successful treatment of thrombotic thrombocytopenic purpura post autologous bone marrow transplant in a child. Bone Marrow Transplant 25:679\u2013680","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajh.2830340303","volume":"34","author":"Byrnes","year":"1990","unstructured":"Byrnes JJ, Moake JL, Klug P, Periman P (1990) Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34:169\u2013174","journal-title":"Am J Hematol"},{"key":"1146_CR108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","volume":"94","author":"Rock","year":"1996","unstructured":"Rock G, Shumak KH, Sutton DMC, Buskard NA, Nair RC, Adams G, Benny B, Caplan SN, Card R, Clark WF, Ford P, Freedman JJL, Gordon P, Klassen J, Leblond P, LepineMartin M, McBride J, Monte MP, Scott S, Sternbach M (1996) Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 94:383\u2013386","journal-title":"Br J Haematol"},{"key":"1146_CR109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/08880019609030844","volume":"13","author":"Kumar","year":"1996","unstructured":"Kumar M, Kedar A, Neiberger RE (1996) Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Pediatr Hematol Oncol 13:375\u2013379","journal-title":"Pediatr Hematol Oncol"},{"key":"1146_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1703312","volume":"29","author":"Frisk","year":"2002","unstructured":"Frisk P, Bratteby LE, Carlson K, Lonnerholm G (2002) Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29:129\u2013136","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR111","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1523-1755.2000.00241.x","volume":"58","author":"Cohen","year":"2000","unstructured":"Cohen EP (2000) Radiation nephropathy after bone marrow transplantation. Kidney Int 58:903\u2013918","journal-title":"Kidney Int"},{"key":"1146_CR112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000188587","volume":"70","author":"Cohen","year":"1995","unstructured":"Cohen EP, Lawton CA, Moulder JE (1995) Bone marrow transplant nephropathy\u2014radiation nephritis revisited. Nephron 70:217\u2013222","journal-title":"Nephron"},{"key":"1146_CR113","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/ajkd.2000.9787","volume":"36","author":"Imai","year":"2000","unstructured":"Imai H, Oyama Y, Miura AB, Endoh M, Sakai H (2000) Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 36:474\u2013480","journal-title":"Am J Kidney Dis"},{"key":"1146_CR114","first-page":"129","volume":"8","author":"Lonnerholm","year":"1991","unstructured":"Lonnerholm G, Carlson K, Bratteby LE, Backlund L, Hagberg H, Rikner G, Smedmyr B, Oberg G, Simonsson B (1991) Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 8:129\u2013134","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR115","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","volume":"13","author":"Butcher","year":"1999","unstructured":"Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP (1999) Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 13:330\u2013335","journal-title":"Clin Transplant"},{"key":"1146_CR116","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000045085","volume":"79","author":"Cohen","year":"1998","unstructured":"Cohen EP, Piering WF, Kabler BC, Moulder JE (1998) End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79:408\u2013412","journal-title":"Nephron"},{"key":"1146_CR117","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0140-6736(00)03561-3","volume":"357","author":"Cohen","year":"2001","unstructured":"Cohen EP (2001) Renal failure after bone-marrow transplantation. Lancet 357:6\u20137","journal-title":"Lancet"},{"key":"1146_CR118","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V661661","volume":"6","author":"Leblond","year":"1995","unstructured":"Leblond V, Sutton L, Jacquiaud C, Item C, Sadoun R, Jaudon MC, Raymond F, Jacobs C, Deray G (1995) Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 6:1661\u20131665","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR119","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/1097-0142(19910601)67:11<2795::AID-CNCR2820671114>3.0.CO;2-D","volume":"67","author":"Lawton","year":"1991","unstructured":"Lawton CA, Cohen EP, Barberderus SW, Murray KJ, Ash RC, Casper JT, Moulder JE (1991) Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67:2795\u20132800","journal-title":"Cancer"},{"key":"1146_CR120","first-page":"1680","volume":"98","author":"Cahn","year":"2001","unstructured":"Cahn JY, Kribs M, Deconinck E, Rebibou JM, Challier B, Tiberghien P, Chalopin JM (2001) Chronic renal failure: an underestimated complication of allogeneic bone marrow transplantation. Blood 98:1680","journal-title":"Blood"},{"key":"1146_CR121","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bmt.1701169","volume":"21","author":"Natazuka","year":"1998","unstructured":"Natazuka T, Kajimoto K, Ogawa R, Imoto S, Koizumi T, Nishimura R, Nakagawa T (1998) Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies. Bone Marrow Transplant 21:815\u2013819","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR122","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.bmt.1701151","volume":"21","author":"Kanamori","year":"1998","unstructured":"Kanamori H, Maruta A, Sasaki S, Yamazaki E, Ueda S, Katoh K, Tamura T, Otsuka-Aoba M, Taguchi J, Harano H, Ogawa K, Mohri H, Okubo T, Matsuzaki M, Watanabe S, Koharazawa H, Fujita H, Kodama F (1998) Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 21:705\u2013709","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR123","first-page":"396","volume":"68","author":"Jaenke","year":"1993","unstructured":"Jaenke RS, Robbins MEC, Bywaters T, Whitehouse E, Rezvani M, Hopewell JW (1993) Capillary endothelium\u2014target site of renal radiation-injury. Lab Invest 68:396\u2013405","journal-title":"Lab Invest"},{"key":"1146_CR124","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0889-8588(05)70348-8","volume":"10","author":"Moake","year":"1996","unstructured":"Moake JL, Byrnes JJ (1996) Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 10:485\u2013497","journal-title":"Hematol Oncol Clin North Am"},{"key":"1146_CR125","first-page":"195a","volume":"98","author":"Elliott","year":"2001","unstructured":"Elliott MA, Nichols WL, Plumhoff EA, Ansell SM, Dispenzieri A, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Tefferi A, Litzow MR (2001) Post-transplant thrombotic thrombocytopenic purpura (TTP), a complication of high risk myeloablative and non-myeloablative transplantation, is not associated with von Willebrand factor-cleaving protease (vWF-CP) deficiency (abstract). Blood 98:195a","journal-title":"Blood"},{"key":"1146_CR126","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.bmt.1701890","volume":"24","author":"Takatsuka","year":"1999","unstructured":"Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H, Okada M, Kanamaru A, Kakishita E (1999) Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 24:303\u2013306","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR127","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ki.1989.132","volume":"35","author":"Antignac","year":"1989","unstructured":"Antignac C, Gubler MC, Leverger G, Broyer M, Habib R, Lacoste M, Beziau A, Naizot C (1989) Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 35:1336\u20131344","journal-title":"Kidney Int"},{"key":"1146_CR128","first-page":"818","volume":"98","author":"El","year":"2001","unstructured":"El Seisi S, Gupta R, Miladinovic M, Forrest DL, Clase CM, Couban S (2001) Renal pathology in patients who died following hematopoietic stem cell transplantation. Blood 98:818","journal-title":"Blood"},{"key":"1146_CR129","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000046273","volume":"21","author":"Lin","year":"2001","unstructured":"Lin J, Markowtiz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD, Savage DG (2001) Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation\u2014report of 2 cases and review of the literature. Am J Nephrol 21:351\u2013356","journal-title":"Am J Nephrol"},{"key":"1146_CR130","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000045208","volume":"80","author":"Yorioka","year":"1998","unstructured":"Yorioka N, Taniguchi Y, Shimote K, Komo T, Yamakido M, Hyodo H, Kimura A, Taguchi T (1998) Membranous nephropathy with chronic graft-versus-host disease in a bone marrow transplant recipient (letter). Nephron 80:371\u2013372","journal-title":"Nephron"},{"key":"1146_CR131","first-page":"303","volume":"16","author":"Sato","year":"1995","unstructured":"Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H, Nishi S, Ueno M, Ito K, Koike T, Takahashi H, Moryama Y, Arakawa M, Shibata A (1995) Nephrotic syndrome in a bone marrow transplant recipient with chronic graft versus host disease. Bone Marrow Transplant 16:303\u2013305","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR132","first-page":"115","volume":"37","author":"Barbara","year":"1992","unstructured":"Barbara JAJ, Thomas AC, Smith PS, Gillis D, Ho J, Woodroffe AJ (1992) Membranous nephropathy with graft versus host disease in a bone marrow transplant recipient. Clin Nephrol 37:115\u2013118","journal-title":"Clin Nephrol"},{"key":"1146_CR133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000185396","volume":"51","author":"Muller","year":"1989","unstructured":"Muller GA, Muller CA, Markoviclipkowski J, Brossbach U, Schmidt H, Ehninger G, Bohle A, Risler T (1989) Membranous nephropathy after bone marrow transplantation in cyclosporine treatment. Nephron 51:555\u2013556","journal-title":"Nephron"},{"key":"1146_CR134","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000045999","volume":"88","author":"Rossi","year":"2001","unstructured":"Rossi L, Cardarelli F, Vampa ML, Buzio C, Olivetti G (2001) Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma. Nephron 88:260\u2013263","journal-title":"Nephron"},{"key":"1146_CR135","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/ndt\/14.10.2461","volume":"14","author":"Nergizoglu","year":"1999","unstructured":"Nergizoglu G, Keven K, Ates K, Ustun C, Tulunay O, Beksac M, Karatan O, Ertug AE (1999) Chronic graft-versus-host disease complicated by membranous glomerulonephritis. Nephrol Dial Transplant 14:2461\u20132463","journal-title":"Nephrol Dial Transplant"},{"key":"1146_CR136","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0272-6386(95)90503-0","volume":"26","author":"Walker","year":"1995","unstructured":"Walker JV, Morich D, Anasetti C (1995) Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis 26:532\u2013534","journal-title":"Am J Kidney Dis"},{"key":"1146_CR137","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.bmt.1701527","volume":"23","author":"Oliveira","year":"1999","unstructured":"Oliveira JSR, Bahia D, Franco M, Balda C, Stella S, Kerbauy J (1999) Nephrotic syndrome as a clinical manifestation of graft-versus- host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 23:99\u2013101","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR138","first-page":"503","volume":"99","author":"Chien","year":"2000","unstructured":"Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK (2000) Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. JFormos Med Assoc 99:503\u2013506","journal-title":"JFormos Med Assoc"},{"key":"1146_CR139","first-page":"357","volume":"3","author":"Gomezgarcia","year":"1988","unstructured":"Gomezgarcia P, Herreraarroyo C, Torresgomez A, Gomezcarrasco J, Aljamagarcia P, Lopezrubio F, Martinezguibelalde F, Fornestorres G, Rojasconteras R (1988) Renal involvement in chronic graft-versus-host disease. A report of 2 cases. Bone Marrow Transplant 3:357\u2013362","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2307\/3579870","volume":"150","author":"Moulder","year":"1998","unstructured":"Moulder JE, Fish BL, Cohen EP (1998) Brief pharmacological intervention in experimental radiation nephropathy. Radiat Res 150:535\u2013541","journal-title":"Radiat Res"},{"key":"1146_CR141","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0167-8140(97)00175-8","volume":"46","author":"Moulder","year":"1998","unstructured":"Moulder JE, Fish BL, Cohen EP (1998) Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist. Radiother Oncol 46:307\u2013315","journal-title":"Radiother Oncol"},{"key":"1146_CR142","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/095530098142257","volume":"73","author":"Moulder","year":"1998","unstructured":"Moulder JE, Fish BL, Cohen EP (1998) Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy. Int J Radiat Biol 73:415\u2013421","journal-title":"Int J Radiat Biol"},{"key":"1146_CR143","unstructured":"Cohen EP, Lawton CA (1997) Pathogenesis, prevention and managementof radiation nephropathy. In: Tobias JS, Thomas PRM (eds) Current radiation oncology. Oxford University Press, pp 94"},{"key":"1146_CR144","first-page":"107","volume":"4","author":"VonDerHardt","year":"1997","unstructured":"VonDerHardt K, Zimmerhackl LB, DeBroe ME, Niemeyer CM, Nuyts GD, Brandis M (1997) Indicators of acute nephrotoxicity during non-cisplatinum chemotherapy in childhood. Int J Pediatr Hematol Oncol 4:107\u2013119","journal-title":"Int J Pediatr Hematol Oncol"},{"key":"1146_CR145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF00190337","volume":"71","author":"Brandis","year":"1993","unstructured":"Brandis M, Hardt K von der, Zimmerhackl RB, Mohrmann M, Leititis J (1993) Cytostatics-induced tubular toxicity. Clin Invest 71:855\u2013857","journal-title":"Clin Invest"},{"key":"1146_CR146","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10428199609051765","volume":"22","author":"Crook","year":"1996","unstructured":"Crook M, Swaminathan R, Schey S (1996) Hypophosphataemia in patients undergoing bone marrow transplantation. Leuk Lymphoma 22:335\u2013337","journal-title":"Leuk Lymphoma"},{"key":"1146_CR147","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/sj.bmt.1702838","volume":"27","author":"Raanani","year":"2001","unstructured":"Raanani P, Levi I, Holzman F, Grotto I, Brok-Simoni F, Avigdor A, Davidson J, Shpilberg O, Ben Bassat I (2001) Engraftment associated hypophosphatemia\u2014the role of cytokine release and steep leukocyte rise post stem cell transplantation. Bone Marrow Transplant 27:311\u2013317","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR148","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.0590062377.x","volume":"59","author":"Levi","year":"2001","unstructured":"Levi M (2001) Post-transplant hypophosphatemia. Kidney Int 59:2377\u20132387","journal-title":"Kidney Int"},{"key":"1146_CR149","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1034\/j.1399-3046.1999.00009.x","volume":"3","author":"Legault","year":"1999","unstructured":"Legault L, Bonny Y (1999) Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 3:60\u201366","journal-title":"Pediatr Transplant"},{"key":"1146_CR150","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bmt.1702131","volume":"25","author":"Nysom","year":"2000","unstructured":"Nysom K, Holm K, Michaelsen KF, Hertz H, Jacobsen N, Muller J, Molgaard C (2000) Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 25:191\u2013196","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR151","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004310050006","volume":"159","author":"Bakker","year":"2000","unstructured":"Bakker B, Massa GG, Oostdijk W, Weel-Sipman MH, Vossen JM, Wit JM (2000) Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 159:31\u201337","journal-title":"Eur J Pediatr"},{"key":"1146_CR152","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(SICI)1096-911X(199911)33:5<455::AID-MPO4>3.0.CO;2-3","volume":"33","author":"Arikoski","year":"1999","unstructured":"Arikoski P, Kroger H, Riikonen P, Parviainen MT, Voutilainen R, Komulainen J (1999) Disturbance in bone turnover in children with malignancy at completion of chemotherapy. Med Pediatr Oncol 33:455\u2013461","journal-title":"Med Pediatr Oncol"},{"key":"1146_CR153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.80.2.143","volume":"80","author":"Arikoski","year":"1999","unstructured":"Arikoski P, Komulainen J, Riikonen P, Jurvelin JS, Voutilainen R, Kroger H (1999) Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80:143\u2013148","journal-title":"Arch Dis Child"},{"key":"1146_CR154","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0959-8049(99)00143-4","volume":"35","author":"Boot","year":"1999","unstructured":"Boot AM, Heuvel-Eibrink MM van den, H\u00e4hlen K, Krenning EP, deMuinck Keizer-Schrama SMPF (1999) Bone mineral density in children with acute lymphoblastic leukaemia. Eur J Cancer 35:1693\u20131697","journal-title":"Eur J Cancer"},{"key":"1146_CR155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3476(96)70119-1","volume":"129","author":"Clement-De","year":"1996","unstructured":"Clement-De BA, Oostdijk W, Van-Weel-Sipman MH, Van-den-Broeck J, Wit JM, Vossen JM (1996) Final height and hormonal function after bone marrow transplantation in children. J Pediatr 129:544\u2013550","journal-title":"J Pediatr"},{"key":"1146_CR156","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00043426-199807000-00008","volume":"20","author":"Henderson","year":"1998","unstructured":"Henderson RC, Madsen CD, Davis C, Gold SH (1998) Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol 20:322\u2013326","journal-title":"J Pediatr Hematol Oncol"},{"key":"1146_CR157","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/sj.bmt.1701989","volume":"24","author":"Kauppila","year":"1999","unstructured":"Kauppila M, Irjala K, Koskinen P, Pulkki K, Sonninen P, Viikari J, Remes K (1999) Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant 24:885\u2013889","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR158","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/sj.bmt.1702021","volume":"24","author":"Hovi","year":"1999","unstructured":"Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P (1999) Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 24:1131\u20131136","journal-title":"Bone Marrow Transplant"},{"key":"1146_CR159","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1053\/ctrv.2000.0180","volume":"26","author":"Leeuwen","year":"2000","unstructured":"Leeuwen BL van, Kamps WA, Jansen HWB, Hoekstra HJ (2000) The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363\u2013376","journal-title":"Cancer Treat Rev"},{"key":"1146_CR160","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1359\/jbmr.1999.14.12.2010","volume":"14","author":"Kaste","year":"1999","unstructured":"Kaste SC, Chesney RW, Hudson MM, Lustig RH, Rose SR, Carbone LD (1999) Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health. J Bone Miner Res 14:2010\u20132014","journal-title":"J Bone Miner Res"},{"key":"1146_CR161","first-page":"399a","volume":"98","author":"Giardina","year":"2001","unstructured":"Giardina P, Vogiatzi M, Boulad F, Schneider R, Autio K, Sklar C, O'Reilly R (2001) Spinal bone mineral density in patients with thalassemia post bone marrow transplant. Blood 98:399a","journal-title":"Blood"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-003-1146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-003-1146-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-003-1146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T07:02:23Z","timestamp":1665212543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-003-1146-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,29]]},"references-count":161,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s00467-003-1146-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,29]]}}}